Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 3, 2015, Pages 585-593

  Berry, Kristin ^a   Taylor, Justin ^b   Liou, Iris W ^b   Ioannou, George N ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cirrhosis; Liver transplantation; MELD; Mortality; Portal vein thrombosis; Survival; UNOS

Indexed keywords

SERUM ALBUMIN;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; NONALCOHOLIC FATTY LIVER; PORTAL VEIN THROMBOSIS; PRIMARY SCLEROSING CHOLANGITIS; SURVIVAL; ADOLESCENT; AGED; COHORT ANALYSIS; COMPLICATION; MIDDLE AGED; PATHOLOGY; PORTAL VEIN; RISK ASSESSMENT; THROMBOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MORTALITY; PORTAL VEIN; RISK ASSESSMENT; SURVIVAL ANALYSIS; THROMBOSIS; YOUNG ADULT;

EID: 84925321426     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.10.010     Document Type: Article

References (19)

1. Englesbe M.J., Kubus J., Muhammad W., et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl 2010, 16:83-90.
2. Amitrano L., Guardascione M.A., Brancaccio V., et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. JHepatol 2004, 40:736-741.
3. Available from: United Network for Organ Sharing . Accessed Ocotber 1, 2014. http://www.unos.org.
4. Cox D.R. Regression models and life tables. JRoyal Stat Soc Ser B 1972, 34:187-202.
5. Gray B. Cmprsk: subdistribution analysis of competing risks. R package version 2.2-6. 2013. Available from: . Accessed April 23, 2014. http://CRAN.R-project.org/package%3Dcmprsk.
6. R Core Team (2013). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available from: . Accessed April 23, 2014. http://www.R-project.org/.
7. Pintilie M. Competing risks: A practical perspective 2006, John Wiley & Sons, Chichester, England.
8. Zocco M.A., Di Stasio E., De Cristofaro R., et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. JHepatol 2009, 51:682-689.
9. Maruyama H., Okugawa H., Takahashi M., et al. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol 2013, 108:568-574.
10. Janssen H.L., Wijnhoud A., Haagsma E.B., et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001, 49:720-724.
11. Englesbe M.J., Schaubel D.E., Cai S., et al. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl 2010, 16:999-1005.
12. John B.V., Konjeti R., Aggarwal A., et al. Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis. Ann Hepatol 2013, 12:952-958.
13. Luca A., Caruso S., Milazzo M., et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology 2012, 265:124-132.
14. DeLeve L.D., Valla D.C., Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009, 49:1729-1764. American Association for the Study Liver Disease.
15. Amitrano L., Guardascione M.A., Menchise A., et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. JClin Gastroenterol 2010, 44:448-451.
16. Delgado M.G., Seijo S., Yepes I., et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 2012, 10:776-783.
17. Huard G., Bilodeau M. Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review. Int J Hepatol 2012, 2012:672986.
18. Francoz C., Belghiti J., Vilgrain V., et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005, 54:691-697.
19. Villa E., Camma C., Marietta M., et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 2012, 143:1253-1260 e1-4.